Skip to Content

Join the 'Brivaracetam' group to help and get support from people like you.

Brivaracetam News

FDA Approves New indication for Briviact (brivaracetam) as Monotherapy Treatment of Partial-Onset Seizures in Adults

Posted 20 Sep 2017 by Drugs.com

Atlanta, Georgia (U.S.) & Brussels (Belgium), 15 September, 2017 – 0700 (CEST): UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Briviact (brivaracetam) CV as monotherapy for partial-onset (focal) seizures (POS) in patients 16 years and older with epilepsy.1 This is a new indication for Briviact, which is already a ...

Briviact Approved for Epileptic Seizures

Posted 24 Feb 2016 by Drugs.com

FRIDAY, Feb. 19, 2016 – Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy. Partial onset seizures describe those that originate in a limited area of the brain, the FDA said Friday in a news release. Epilepsy, a common disorder believed to affect more than 5 million people in the United ...

FDA Approves Briviact (brivaracetam) to Treat Partial Onset Seizures

Posted 24 Feb 2016 by Drugs.com

February 19, 2016 – The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy. Epilepsy is a brain disorder that causes people to have recurring seizures. A seizure is an episode, usually of relatively short duration, of abnormal brain activity. ...

Ask a Question

Further Information

Related Condition Support Groups

Seizures

Related Drug Support Groups

Briviact

Brivaracetam Patient Information at Drugs.com